Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Adenocarcinoma 1

Interventions

Gemcitabine 7Albumin-Bound Paclitaxel 5Taxes 4Fluorouracil 4dehydroftorafur 3Radiotherapy 3Oxaliplatin 3Radiotherapy, Intensity-Modulated 2Losartan 2Leucovorin 2Irinotecan 2130-nm albumin-bound paclitaxel 2irinotecan sucrosofate 1indusatumab 1X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1S 1 (combination) 1Radiotherapy, Image-Guided 1Radiation 1Pancreatectomy 1Folfox protocol 1Erlotinib Hydrochloride 1Cetuximab 1Capecitabine 1Anesthesia, General 1Anesthesia 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pancreatic Adenocarcinoma × Anesthesia, General × Clear all
NCT04992507 2025-07-10

Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study

Ohio State University Comprehensive Cancer Center

Phase 2 Terminated
8 enrolled 7 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡